Initial Assessment of 18FDG-PET/MRIin Determining the Extent of Systemic Disease in Breast Cancer Patients
NACompletedINTERVENTIONAL
Enrollment
80
Participants
Timeline
Start Date
July 31, 2012
Primary Completion Date
October 5, 2021
Study Completion Date
October 5, 2021
Conditions
Breast Cancer
Interventions
PROCEDURE
PET/MRI
PET/MRI
Trial Locations (1)
10016
NYU School of Medicine, New York
All Listed Sponsors
lead
NYU Langone Health
OTHER
NCT01672021 - Initial Assessment of 18FDG-PET/MRIin Determining the Extent of Systemic Disease in Breast Cancer Patients | Biotech Hunter | Biotech Hunter